AVIEW Lung Nodule CAD vs DeepTek CXR Analyzer

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AVIEW Lung Nodule CAD

by Coreline Soft

DeepTek CXR Analyzer

by DeepTek

AI Verdict

AVIEW Lung Nodule CAD specializes in detailed analysis of chest CT scans for lung nodule detection, quantification, and comprehensive screening for lung cancer, COPD, and coronary artery calcification. In contrast, DeepTek CXR Analyzer is an AI-powered CADe solution for chest X-rays, focusing on broad detection of suspicious regions across various lung, pleural, and cardiac pathologies to enhance workflow efficiency. While both tools assist radiologists in chest imaging, their distinct imaging modalities and specific analytical depths position them for different diagnostic stages and clinical applications.

Choose AVIEW Lung Nodule CAD if…

Choose AVIEW Lung Nodule CAD if your practice primarily utilizes chest CT scans for comprehensive lung cancer screening and requires detailed quantitative analysis of pulmonary nodules. This tool is ideal for precise nodule characterization, tracking volume doubling time for follow-up, and simultaneously assessing emphysema and coronary artery calcification.

View AVIEW Lung Nodule CAD →

Choose DeepTek CXR Analyzer if…

Choose DeepTek CXR Analyzer if your workflow involves a high volume of chest X-rays and you need an AI-powered solution for rapid initial screening and detection of a broad range of common pathologies. This tool is best suited for improving radiologist efficiency by automatically highlighting suspicious regions and segregating scans, thereby streamlining the interpretation process.

View DeepTek CXR Analyzer →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	AVIEW Lung Nodule CAD	DeepTek CXR Analyzer
Pricing	Unknown	Global access pricing available for eligible public sector and not-for-profit healthcare providers in 138 low- and middle-income countries, offering unlimited ai analyses per connected x-ray unit, installation, user training, product updates, maintenance, and technical support via an annual subscription.
Deployment	On-premises and cloud environment	On-premise and Cloud offerings. The solution supports online, offline, and hybrid deployment.
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

DeepTek CXR Analyzer

DeepTek CXR Analyzer explicitly highlights its ability to reduce radiologist workload by 30-50% and boost productivity by 2x-3x through intelligent segregation of scans. Its seamless DICOM integration and generation of secondary capture DICOM with AI output are designed for straightforward interpretation and workflow efficiency.

Clinical Value

AVIEW Lung Nodule CAD

AVIEW Lung Nodule CAD offers a comprehensive analysis on CT scans, including 3D nodule quantification, Lung-RADS classification, and volume doubling time calculation. Its unique 'Big 3' feature simultaneously analyzes lung nodules, emphysema, and coronary artery calcification, providing a deeper and multi-faceted diagnostic insight crucial for detailed patient management.

Pricing & Value

DeepTek CXR Analyzer

While both tools require contacting sales for pricing, DeepTek CXR Analyzer explicitly states a 'pay-per-use' model. This pricing structure offers greater transparency and flexibility, potentially providing better value for organizations with varying workloads by aligning costs directly with usage.

Enterprise Readiness

AVIEW Lung Nodule CAD

Both tools are FDA-cleared and HIPAA compliant, demonstrating strong foundational readiness. However, AVIEW Lung Nodule CAD offers a wider array of deployment options, including cloud-based, hybrid, locally on dedicated hardware, and locally virtualized (VM, Docker), providing superior flexibility for integration into diverse enterprise IT infrastructures.

Innovation

AVIEW Lung Nodule CAD

AVIEW Lung Nodule CAD stands out with its 'Big 3' simultaneous analysis, integrating lung nodule detection, emphysema quantification, and coronary artery calcification scoring from a single CT scan. This multi-organ, multi-disease approach represents a significant innovation in comprehensive patient assessment and risk stratification.

Support & Docs

Tie

The provided structured facts and web searches indicate that both Coreline Soft and DeepTek mention offering support and training. However, there is insufficient specific information available for either tool regarding the depth of documentation, support channels, or service level agreements to definitively distinguish between them.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	AVIEW Lung Nodule CAD	DeepTek CXR Analyzer
Primary Imaging Modality	Chest CT scans	Chest X-rays
Core AI Function	AI-based pulmonary nodule detection (3-20 mm), classification, 3D quantification, VDT calculation, simultaneous analysis of lung nodules, emphysema, and coronary artery calcification.	AI-powered Computer-Assisted Detection (CADe) for Chest X-rays, detecting and highlighting suspicious regions across lung, pleural, and cardiac pathologies, and hardware.
Number of Detected Findings/Pathologies	Lung nodules, emphysema, and coronary artery calcification (Big 3)	28 findings covering lung, pleural, cardiac pathologies, and hardware
Specialties	Cardiology, Pulmonology, Radiology	Cardiology, Pulmonology, Radiology
Additional Quantitative Analysis	3D nodule size and volume quantification, Nodule matching and volume doubling time (VDT) calculation, Quantitative emphysema analysis (e.g., LAA, emphysema index), Coronary Artery Calcification (CAC) scoring (Agatston, volume, mass scores).	Not specified

Videos

Demos, reviews, and walkthroughs featuring AVIEW Lung Nodule CAD and DeepTek CXR Analyzer.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What types of medical images do these AI tools analyze?

AVIEW Lung Nodule CAD is designed for analyzing chest CT scans, assisting in the detection and analysis of pulmonary nodules. DeepTek CXR Analyzer is an AI-powered CADe solution specifically for chest X-ray analysis, detecting suspicious regions across various pathologies.

What specific pathologies or findings can each tool detect?

AVIEW Lung Nodule CAD focuses on AI-based pulmonary nodule detection (3-20 mm), nodule classification, 3D size and volume quantification, and simultaneous analysis of emphysema and coronary artery calcification. DeepTek CXR Analyzer detects 28 findings covering lung, pleural, cardiac pathologies, and hardware on chest X-rays.

How do these tools integrate into the diagnostic workflow and what kind of output do they provide?

AVIEW Lung Nodule CAD generates automatic reports based on Lung-RADS classification and calculates nodule volume doubling time for follow-up comparisons. DeepTek CXR Analyzer automatically identifies, categorizes, and highlights suspicious regions of interest, segregating scans into 'AI Finding-Negative' and 'AI Finding-Positive,' and generates secondary capture DICOM with AI output for easy interpretation.

Do these tools offer quantitative analysis capabilities?

AVIEW Lung Nodule CAD provides detailed quantitative analysis including 3D nodule size and volume quantification, quantitative emphysema analysis (e.g., Low Attenuation Area - LAA, emphysema index), and Coronary Artery Calcification (CAC) scoring (Agatston, volume, mass scores). DeepTek CXR Analyzer focuses on detection and highlighting of suspicious regions for various pathologies, aiming to reduce radiologist workload and boost productivity.